Modulation of cortisol responses to the DEX/CRH test by polymorphisms of the interleukin-1beta gene in healthy adults. 2011

Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan. sasayama@shinshu-u.ac.jp

BACKGROUND Recently, hypothalamus-pituitary-adrenal (HPA) axis function assessed with the combined dexamethasone (DEX)/corticotropin releasing hormone (CRH) test has been shown to be associated with response to antidepressant treatment. A polymorphism (rs16944) in the interleukin-1beta (IL-1β) gene has also been reported to be associated with the medication response in depression. These findings prompted us to examine the possible association between IL-1β gene polymorphisms and HPA axis function assessed with the DEX/CRH test. METHODS DEX/CRH test was performed in 179 healthy volunteers (45 males: mean age 40.5 ± 15.8 years; 134 females: mean age 47.1 ± 13.2 years). Five tagging single nucleotide polymorphisms (SNPs) of IL-1β gene (rs2853550, rs1143634, rs1143633, rs1143630, rs16944) were selected at an r2 threshold of 0.80 with a minor allele frequency > 0.1. Genotyping was performed by the TaqMan allelic discrimination assay. A two-way factorial analysis of variance (ANOVA) was performed with the DEX/CRH test results as the dependent variable and genotype and gender as independent variables. To account for multiple testing, P values < 0.01 were considered statistically significant for associations between the genotypes and the cortisol levels. RESULTS The cortisol levels after DEX administration (DST-Cortisol) showed significant associations with the genotypes of rs16944 (P = 0.00049) and rs1143633 (P = 0.0060), with no significant gender effect or genotype × gender interaction. On the other hand, cortisol levels after CRH administration (DEX/CRH-Cortisol) were affected by gender but were not significantly influenced by the genotype of the examined SNPs, with no significant genotype × gender interaction. CONCLUSIONS Our results suggest that genetic variations in the IL-1β gene contribute to the HPA axis alteration assessed by DST-Cortisol in healthy subjects. On the other hand, no significant associations of the IL-1β gene polymorphisms with the DEX/CRH-Cortisol were observed. Confirmation of our findings in futures studies may add new insight into the communication between the immune system and the HPA axis.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010912 Pituitary-Adrenal Function Tests Tests that evaluate the adrenal glands controlled by pituitary hormones. Function Test, Pituitary-Adrenal,Function Tests, Pituitary-Adrenal,Pituitary Adrenal Function Tests,Pituitary-Adrenal Function Test,Test, Pituitary-Adrenal Function,Tests, Pituitary-Adrenal Function
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
April 2008, Hormones and behavior,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
September 2009, Psychoneuroendocrinology,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
March 2013, Psychoneuroendocrinology,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
August 2012, Psychoneuroendocrinology,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
November 2011, Journal of psychiatric research,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
June 2011, Psychoneuroendocrinology,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
April 2010, Psychoneuroendocrinology,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
September 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
January 2009, PloS one,
Daimei Sasayama, and Hiroaki Hori, and Yoshimi Iijima, and Toshiya Teraishi, and Kotaro Hattori, and Miho Ota, and Takashi Fujii, and Teruhiko Higuchi, and Naoji Amano, and Hiroshi Kunugi
August 2005, Chest,
Copied contents to your clipboard!